Anzeige
Mehr »
Mittwoch, 12.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5V2 | ISIN: SE0005454873 | Ticker-Symbol: 4YD
Frankfurt
11.08.26 | 08:02
0,031 Euro
0,00 % 0,000
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOLOGICA AB Chart 1 Jahr
5-Tage-Chart
NANOLOGICA AB 5-Tage-Chart

Aktuelle News zur NANOLOGICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.05.Nanologica AB: Bulletin from the Annual General Meeting 2026 Nanologica AB (publ)420Nanologica AB (publ) today May 21, 2026 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition...
► Artikel lesen
20.05.Nanologica AB: Interim Report Q1 2026 Nanologica AB (publ)563FINANCIAL SUMMARYNet sales for the first quarter amounted to SEK 21,456 thousand (10,751).Operating profit for the quarter amounted to SEK 66,484 thousand (-9,241). Operating profit is affected by the...
► Artikel lesen
27.04.Nanologica AB: Syntagon AB Recruits Alexandra Pichard Nielsen as Vice President Business Development807Syntagon AB, a subsidiary of Nanologica AB (publ), has recruited Alexandra Pichard Nielsen to the newly established role of Vice President Business Development. The recruitment is part of the strategy...
► Artikel lesen
NANOLOGICA Aktie jetzt für 0€ handeln
26.03.Nanologica AB: Nanologica Announces Outcome of Rights Issue881NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
06.03.Nanologica AB: Nanologica Publishes Information Document Regarding Directed Share Issues and Rights Issue729NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
05.03.XFRA CAPITAL ADJUSTMENT INFORMATION - 05.03.2026492Das Instrument 4YD SE0005454873 NANOLOGICA AB EQUITY wird cum Kapitalmassnahme gehandelt am 05.03.2026 und ex Kapitalmassnahme am 06.03.2026 The instrument 4YD SE0005454873 NANOLOGICA AB EQUITY is traded...
► Artikel lesen
04.03.Nanologica AB: Bulletin From The Extraordinary General Meeting In Nanologica AB (publ)443Nanologica AB (publ) ("Nanologica" or the "Company") held an extraordinary general meeting today at which the following resolutions were passed. For more detailed information on the content of the resolutions...
► Artikel lesen
26.02.Nanologica AB: Year-End Report 2025 Nanologica AB (publ)570FINANCIAL SUMMARYNet sales for the fourth quarter amounted to SEK 5,205 thousand (6,715) and for the full year to SEK 21,127 thousand (14,538)Operating loss for the quarter amounted to SEK -15,706 thousand...
► Artikel lesen
02.02.Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon596Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity...
► Artikel lesen
30.01.Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million831NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
29.01.Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica801Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of...
► Artikel lesen
23.10.25Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ)737FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10...
► Artikel lesen
22.10.25Nanologica AB: Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China530Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers. "This...
► Artikel lesen
01.10.25Nanologica AB: Nanologica AB (publ) Enters the Insulin Market in China461Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media NLAB Saga®. The customer is an insulin manufacturer...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1